Riskpilot← Back to searchSign inGet full accessSØRLANDSAPOTEKENE AS
ASActiveOrg 995142740Hølleheiveien 41, 4640 SøgneRetail sale of pharmaceutical products · NACE 4773Est. 20100 employeeswww.utleiefarmasoytene.no
Revenue 2025
NOK 0
EBITDA margin
—
+40% vs 2024
Equity ratio
37.0%
Financial strength
Net profit 2025
NOK 620K
+2557% vs 2024
| Revenue | NOK 0 | — |
| EBITDA | NOK -15K | +40% |
| Net profit | NOK 620K | +2557% |
| Total assets | NOK 843K | +3999% |
| Equity | NOK 312K | +390% |
| Employees | 0 | — |
Legal name
SØRLANDSAPOTEKENE AS
Org number
995142740
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
15. februar 2010
Share capital
NOK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene. Daglig leder alene.
Company purpose
Bemanningsformidling til farmasirelaterte foretak, samt deltakelse i andre foretak med farmasi relatert virksomhet. Selskapet skal og så investere i finansielle instrumenter og fast eiendom.
Address
Hølleheiveien 41, 4640 Søgne
Website
www.utleiefarmasoytene.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 120 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −39 | −3 868 | −288 | −25 | −15 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −39 | −3 868 | −288 | −25 | −15 |
| Net financials | −0 | −50 | 0 | 0 | 635 |
| Profit before tax | −40 | −3 918 | −288 | −25 | 620 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −40 | −3 918 | −288 | −25 | 620 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 5 125 | 230 | −78 | 21 | 843 |
| Equity | 4 123 | 206 | −82 | −108 | 312 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 002 | 24 | 4 | 128 | 531 |
| Total debt | 1 002 | 24 | 4 | 128 | 531 |
EBITDA margin
-1515600.0%
This company
15.8%
Market median
-9592505% vs market
20212025
Equity ratio
37.0%
This company
38.2%
Market median
+3% vs market
20212025
Return on equity
198.6%
This company
18.4%
Market median
+979% vs market
20212025
Net profit margin
61973000.0%
This company
8.1%
Market median
+765098665% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
1.70×
This company
0.62×
Market median
-174% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SH Chief Executive Officer | Chief Executive Officer | 2010 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SØRLANDSAPOTEKENE AS 
123APOTEK.NO ASBoard members of SØRLANDSAPOTEKENE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sverre Høyem | Chief Executive Officer | 0 companies |
| Håkon Høyem | Board of Directors | 0 companies |